(Total Views: 388)
Posted On: 06/03/2019 7:10:56 PM
Post# of 153048
Thanks for sharing! I have read this article and it has a lot of useful information even if published in 2008.
One thing I recall and pertains to the CAR-T deletion of CCR5 is this was viewed positively, and thus I was concerned about it being a competitor to leronlimab (when doing my earlier DD). I know these will take quite a bit more time for approval if that ever happens, so I didn’t let that keep me from pursuing CYDY.
One thing I recall and pertains to the CAR-T deletion of CCR5 is this was viewed positively, and thus I was concerned about it being a competitor to leronlimab (when doing my earlier DD). I know these will take quite a bit more time for approval if that ever happens, so I didn’t let that keep me from pursuing CYDY.
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
